Early Risk Stratification of COVID‐19 Associated Cytokine Storm Using a Four‐Cytokine Cumulative Score: A Retrospective Cohort Study
Journal of Medical Virology · 2026-11 · 98 (11)
DOI: 10.1002/jmv.71191 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Medical Virology, online erschienen am 26.10.2026. Verfasst von Junyu Yin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center of Clinical Epidemiology and Biobank, Beijing Youan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: COVID-19, Cytokine Release Syndrome, Cytokines. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Cytokine storm (CS) is a major immunopathological driver of severe illness and death in COVID‐19, yet practical tools for its early identification remain limited. This study aimed to identify early predictive biomarkers, characterize their lead times and develop a cumulative cytokine score for early risk stratification of COVID‐19‐associated CS. In this single‐center retrospective cohort study, 295 hospitalized patients with COVID‐19 were included. Admission cytokines and inflammatory markers were analyzed. Cox proportional hazards models were used to identify predictors of CS and in‐hospital mortality. Receiver operating characteristic analysis was performed to determine optimal cut‐offs, and the interval between biomarker elevation above the cut‐off and CS onset was defined as the early warning interval. A four‐cytokine cumulative score (0–4 points; IL‐6, IL‐8, IL‐10, TNF‐α) was constructed. Internal validation was performed using 2,000 bootstrap resamples. Cytokines increased approximately 4–5 days prior to CS onset, earlier than CRP and d ‐dimer. In the multivariable model integrating clinical variables, a cumulative cytokine score of 3–4 was independently associated with increased CS risk (HR = 4.078, 95% CI: 1.180–14.101, p = 0.026) and higher in‐hospital mortality (HR = 22.026, 95% CI: 2.569–188.846, p = 0.005). The score demonstrated good discriminative performance for CS prediction (AUC = 0.795). A cumulative cytokine score integrating multiple inflammatory pathways may offer a theoretical basis for the early auxiliary diagnosis and risk stratification of COVID‐19–associated CS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Clinical Epidemiology and Biobank, Beijing Youan Hospital, Capital Medical University, Beijing, China.
- Department of Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
- Department of Gastroenterology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Junyu Yin, Shuo Wang, Qingkun Song
Zitieren
APA
Yin, J., Huang, X., Ou, X., Xu, S., Zhang, J., Wang, S., Sun, J., Wu, J., Qiao, G., Cao, Y., & Song, Q. (2026). Early Risk Stratification of COVID‐19 Associated Cytokine Storm Using a Four‐Cytokine Cumulative Score: A Retrospective Cohort Study. Journal of Medical Virology, 98(11). https://doi.org/10.1002/jmv.71191
Vancouver
Yin J, Huang X, Ou X, Xu S, Zhang J, Wang S, et al. Early Risk Stratification of COVID‐19 Associated Cytokine Storm Using a Four‐Cytokine Cumulative Score: A Retrospective Cohort Study. Journal of Medical Virology. 2026;98(11). doi:10.1002/jmv.71191
BibTeX
@article{Yin2026,
author = {Yin, Junyu and Huang, Xianxu and Ou, Xin and Xu, Shilin and Zhang, Jiaying and Wang, Shuo and Sun, Jianping and Wu, Jiangping and Qiao, Guifang and Cao, Yu and Song, Qingkun},
title = {Early Risk Stratification of COVID‐19 Associated Cytokine Storm Using a Four‐Cytokine Cumulative Score: A Retrospective Cohort Study},
journal = {Journal of Medical Virology},
year = {2026},
volume = {98},
number = {11},
doi = {10.1002/jmv.71191}
}
EUVIMED